We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+16.33%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.37B
AUM Growth
+$227M
Cap. Flow
-$5.81M
Cap. Flow %
-0.25%
Top 10 Hldgs %
19.78%
Holding
359
New
114
Increased
58
Reduced
128
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 21.26%
2 Consumer Discretionary 16.72%
3 Industrials 15.68%
4 Technology 14.21%
5 Consumer Staples 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMAN
351
DELISTED
eMagin Corporation
EMAN
$0 ﹤0.01%
+1,000
New +$335
ARNA
352
DELISTED
Arena Pharmaceuticals Inc
ARNA
-287,899
Closed -$13.2M
TIVO
353
DELISTED
Tivo Inc
TIVO
$0 ﹤0.01%
+11
New +$87
LPT
354
DELISTED
Liberty Property Trust
LPT
-8,585
Closed -$441K
OLBK
355
DELISTED
Old Line Bancshares, Inc.
OLBK
-8,000
Closed -$232K
QTWW
356
DELISTED
QUANTUM FUEL SYS TECHNOLOGIES WORLDWIDE INC COM STK (DE)
QTWW
$0 ﹤0.01%
+15
New

Similar funds

Emerald Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Emerald Advisers held 359 positions worth $2.37B, up 11% from $2.14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2019 filing shows 114 new, 58 increased, 128 reduced and 21 closed positions. Its largest new stake was BellRing Brands: 1,634,376 shares worth $34.8M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $33M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Emerald Advisers's largest Q4 2019 buy was BellRing Brands: 1,634,376 shares worth $34.8M.
  • Emerald Advisers added most to Perficient Inc in Q4 2019, an estimated $15.7M increase.
  • Emerald Advisers's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $33M.
  • Emerald Advisers fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $13.2M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.37B portfolio in Q4 2019.
  • Emerald Advisers opened 114 new positions and closed 21 in Q4 2019.
  • Emerald Advisers's portfolio value rose 11% quarter-over-quarter to $2.37B.

Based on Emerald Advisers's 13F filing for Q4 2019, filed 29 Jan 2020.